These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2782322)

  • 1. Second International Symposium on Rilmenidine. Paris, March 11, 1988. Proceedings.
    Am J Med; 1989 Sep; 87(3C):1S-74S. PubMed ID: 2782322
    [No Abstract]   [Full Text] [Related]  

  • 2. Rilmenidine and the high risk hypertensive patient.
    Laragh JH
    Ann N Y Acad Sci; 1995 Jul; 763():634-41. PubMed ID: 7677383
    [No Abstract]   [Full Text] [Related]  

  • 3. Imidazoline Receptors: A Novel Approach to Hypertension--the Contribution of Rilmenidine. Symposium proceedings. Milan, Italy, June 8, 1993.
    Am J Cardiol; 1994 Dec; 74(13):1A-65A. PubMed ID: 7998579
    [No Abstract]   [Full Text] [Related]  

  • 4. Imidazoline Receptors in a Comprehensive Approach to Hypertension. Proceedings of an international symposium. Berlin, Germany, September 10, 1994.
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S1-67. PubMed ID: 8642799
    [No Abstract]   [Full Text] [Related]  

  • 5. [New perspectives in the treatment of hypertension: the contribution of rilmenidine].
    Polónia J
    Rev Port Cardiol; 2000 Apr; 19 Suppl 2():II21-6. PubMed ID: 10874853
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of rilmenidine on the central nervous system and kidney].
    Fillastre JP
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():19-23. PubMed ID: 2517005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of rilmenidine versus captopril on microalbuminuria: a pilot study in hypertensive type 2 diabetics.
    Bauduceau B; Mayaudon H; Dupuy O
    Cardiovasc Drugs Ther; 1999 Nov; 13(6):547-8. PubMed ID: 10686665
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical benefits of rilmenidine.
    Kourilsky O
    Rev Port Cardiol; 2000 Apr; 19 Suppl 2():II27-32. PubMed ID: 10874854
    [No Abstract]   [Full Text] [Related]  

  • 9. [New discoveries in the regulation of arterial pressure: endazoline, rilmenidine and imidazoline receptors].
    Safar ME
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():9-10. PubMed ID: 2517010
    [No Abstract]   [Full Text] [Related]  

  • 10. [The 1989 Bichat Conference. A new therapeutic orientation in arterial hypertension: the action of rilmenidine (Hyperium 1 mg) on the so-called imidazoline receptors].
    Fillastre JP; Dhib M
    Rev Prat; 1990 Apr; 40(11):1032-3. PubMed ID: 2343243
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current data on the pharmacology of rilmenidine].
    Montastruc JL; Macquin-Mavier I; Damase-Michel C; Dard B; Tran MA; Valet P
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():25-9. PubMed ID: 2517006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined action of multiple antihypertensive mechanisms. Proceedings of an official satellite symposium of the 12th scientific meeting of the International Society of Hypertension. Nara, Japan, 26 May 1988.
    Drugs; 1988; 36 Suppl 6():1-171. PubMed ID: 3267511
    [No Abstract]   [Full Text] [Related]  

  • 13. [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():53-7. PubMed ID: 2534268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension, lipids and alpha-blockade. Proceedings of an international symposium. Paris, France, 27 May, 1989.
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():1-94. PubMed ID: 2575175
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertension, the renin-angiotensin system and perindopril. First International Symposium on Perindopril. Paris, France, October 29, 1989.
    Clin Exp Hypertens A; 1989; 11 Suppl 2():459-623. PubMed ID: 2605797
    [No Abstract]   [Full Text] [Related]  

  • 16. [Albarel (rilmenidin)--a selective I1 imidazole receptor agonist. Pharmacologic properties and experience in clinical use].
    Khirmanov VN
    Ter Arkh; 2003; 75(2):85-8. PubMed ID: 12685403
    [No Abstract]   [Full Text] [Related]  

  • 17. New Challenges in the Treatment of Hypertension, The Global Approach. Proceedings of the 2nd International Mediterranean Symposium on Hypertension. Lisbon, Portugal, 25-28 March 1993.
    Drugs; 1993; 46 Suppl 2():1-213. PubMed ID: 7512461
    [No Abstract]   [Full Text] [Related]  

  • 18. A symposium: The goals of antihypertensive therapy--what really counts? March 26, 1988, Atlanta, Georgia. Proceedings.
    Am J Cardiol; 1989 Jan; 63(4):1B-41B. PubMed ID: 2911993
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind controlled study of rilmenidine versus hydrochlorothiazide in mild hypertension: clinical and renal haemodynamic evaluation.
    Licata G; Scaglione R; Guillet C; Capuana G; Parrinello G; Indovina A; Lipari R; Mazzola G; Merlino G
    J Hum Hypertens; 1993 Apr; 7(2):153-7. PubMed ID: 8510088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pinacidil: potassium channel openers in the treatment of hypertension. Proceedings of a symposium. Copenhagen, 10-11 March, 1988.
    Drugs; 1988; 36 Suppl 7():1-98. PubMed ID: 3254829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.